Status:
COMPLETED
Harvesting Health Program in Improving Diet and Physical Activity Level in Cancer Survivors
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Cancer Survivor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot clinical trial studies the Harvesting Health Program in improving the diet and physical activity level of cancer survivors. Nutrition and physical activity classes and the opportunity to ha...
Detailed Description
PRIMARY OBJECTIVES: I. Measure survivor participation in regards to each aspect of the Harvesting Health Program (personalized and group education, gardening and harvesting, and utilization of novel ...
Eligibility Criteria
Inclusion
- Voluntary agreement to participate and sign an informed consent document
- Adults with the ability to read, write, and speak English who have access to the internet
- Cancer survivors who have completed active cancer treatments within the previous 12 months extended-stage survivors)
- Survivors must have a computer with internet access and an active email account
- Participants must refrain from traveling for more than 3 weeks total during the intervention period
- Participants who are undergoing long-term hormone therapy (i.e., tamoxifen) are permitted to enroll
Exclusion
- Cancer survivors who are cognitively unable to consent or have physical or mental limitations that would prevent full participation in the program
- Adults receiving active treatment including surgery, neoadjuvant hormonal, chemotherapy, or radiation
- Survivors with pre-existing medical conditions that preclude unsupervised physical activity (i.e., severe orthopedic conditions, impending hip or knee replacement, paralysis, unstable angina, dementia, or recent history of myocardial infarction, congestive heart failure, pulmonary conditions that require oxygen, or hospitalization within six months)
- Adults taking any medication that do not allow for increased intake of fruits and vegetables (i.e., pharmacologic doses of warfarin)
- Survivors currently involved in other clinical trials
- Long-term cancer survivors (\> 12 months post treatment)
- Those planning to start certain medications after the trial enrollment or use of non- prescription substances (i.e. saw palmetto and other herbal or alternative products)
- Survivors with active metabolic or digestive illnesses such as malabsorptive disorders (Crohn's, celiac disease, irritable bowel syndrome \[IBS\]), renal insufficiency, hepatic insufficiency, cachexia, or short bowel syndrome
- Pregnant women will be excluded from the study
Key Trial Info
Start Date :
April 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2015
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT02268188
Start Date
April 1 2014
End Date
October 31 2015
Last Update
August 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States, 43210